CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
Titel:
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
Auteur:
Konstantinidis, Evangelos Molisak, Agnieszka Perrin, Florian Streubel-Gallasch, Linn Fayad, Sarah Kim, Daniel Y. Petri, Karl Aryee, Martin J. Aguilar, Ximena György, Bence Giedraitis, Vilmantas Joung, J. Keith Pattanayak, Vikram Essand, Magnus Erlandsson, Anna Berezovska, Oksana Ingelsson, Martin